XML 88 R77.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segments - Adjusted EBITDA (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Adjusted EBITDA    
Net sales $ 363,893 $ 260,432
Cost of goods sold 244,110 176,937
Selling, general and administrative expenses 68,523 65,796
Add: Depreciation and amortization 12,830 9,004
Add: Acquisition-related cost of goods sold 1,117  
Add: Phibro Forward income growth initiatives implementation costs   350
Subtract: Insurance proceeds (3,786)  
Adjusted EBITDA 80,998 46,435
Animal Health    
Adjusted EBITDA    
Net sales 283,456 182,523
Add: Acquisition-related cost of goods sold 1,117  
Subtract: Insurance proceeds (1,177)  
Adjusted EBITDA 74,872 40,385
Mineral Nutrition    
Adjusted EBITDA    
Net sales 62,988 59,062
Adjusted EBITDA 4,523 3,762
Performance Products    
Adjusted EBITDA    
Net sales 17,449 18,847
Adjusted EBITDA 1,603 2,288
Operating Segments    
Adjusted EBITDA    
Add: Depreciation and amortization 12,359 8,512
Operating Segments | Animal Health    
Adjusted EBITDA    
Cost of goods sold 172,872 108,239
Selling, general and administrative expenses 47,251 41,562
Add: Depreciation and amortization 11,599 7,663
Operating Segments | Mineral Nutrition    
Adjusted EBITDA    
Cost of goods sold 57,284 53,887
Selling, general and administrative expenses 1,715 1,929
Add: Depreciation and amortization 534 516
Operating Segments | Performance Products    
Adjusted EBITDA    
Cost of goods sold 13,954 14,818
Selling, general and administrative expenses 2,118 2,074
Add: Depreciation and amortization $ 226 $ 333